Position in ABBV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$67,519,792
+$8,304,878 QoQ
Shares Held
268,319
-1.4% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#318
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vest Financial, LLC holds $177,449,874 across 8 Drug Manufacturers - General names. ABBV ranks #1 (38.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
268,319 | $67,519,792 | |
| 2 | JNJ |
Johnson & Johnson
|
259,276 | $65,848,324 | |
| 3 | LLY |
ELI LILLY & Co
|
14,258 | $17,101,473 | |
| 4 | MRK |
Merck & Co., Inc.
|
85,329 | $10,964,776 | |
| 5 | AMGN |
Amgen Inc
|
23,056 | $8,349,037 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,740 | $3,125,651 | |
| 7 | PFE |
Pfizer Inc
|
101,513 | $2,444,433 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
36,383 | $2,096,388 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,519,792 | 268,319 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $59,214,914 | 272,265 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $57,027,448 | 249,584 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $72,412,282 | 312,742 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $59,810,475 | 322,220 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $70,536,793 | 336,659 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $54,870,560 | 308,782 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $56,534,573 | 286,280 | Shares | Defined | 2024-10-18 | |
| 2024-06-30 | $44,881,637 | 261,670 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $42,312,391 | 232,358 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $28,518,663 | 184,027 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $23,731,246 | 159,206 | Shares | Defined | 2023-10-30 | |
| 2023-06-30 | $10,018,253 | 74,358 | Shares | Defined | 2023-07-28 | |
| 2023-03-31 | $10,926,884 | 68,563 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $9,788,717 | 60,570 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,207,611 | 61,155 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,326,371 | 60,893 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $10,206,931 | 62,963 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $8,435,961 | 62,304 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,782,847 | 44,339 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,053,125 | 35,983 | Shares | Defined | 2021-07-16 | |
| 2021-03-31 | $2,443,282 | 22,577 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $2,722,038 | 25,404 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||